½ÃÀ庸°í¼­
»óǰÄÚµå
1467735

¼¼°èÀÇ ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå º¸°í¼­ : °ø±Þ¿ø, ÇüÅÂ, ±â´É, À¯Åë ä³Î, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)

Omega 3 Supplements Market Report by Source, Form, Functionality, Distribution Channel, End User, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 137 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àü ¼¼°è ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå ±Ô¸ð´Â 2023³â 79¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2032³â±îÁö 147¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÌ¸ç ¿¹Ãø±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.06%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

¿À¸Þ°¡ 3 Áö¹æ»êÀº »ý¼±, ½Ä¹°¼º ±â¸§, °ß°ú·ù, ¾Æ¸¶¾¾, ¾Æ¸¶ ÀÎÀ¯, ÀÙ ¾ßä µîÀÇ ½Äǰ¿¡ ÀÚ¿¬ÀûÀ¸·Î Æ÷ÇԵǴ Çʼö Áö¹æ»êÀÔ´Ï´Ù. ¿À¸Þ°¡ 3 Áö¹æ»êÀº ½ÅüÀÇ ¼¼Æ÷¸·¿¡¼­ ¼¼Æ÷ ¼ö¿ëüÀÇ ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÕ´Ï´Ù. ºÎÁ·Çϸé ÇǺΠ°ÇÁ¶ ¹× ¿°Áõ, ¾È±¸°ÇÁ¶Áõ, ¿ì¿ïÁõ, °üÀý¿° µîÀ» À¯¹ßÇÕ´Ï´Ù. ±× °á°ú, ü³»ÀÇ ¿À¸Þ°¡ 3 ·¹º§À» ³ôÀ̱â À§ÇØ, ½ÃÆÇ(OTC)ÀÇ ¿À¸Þ°¡ 3 º¸ÃæÁ¦ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¸ÃæÁ¦´Â ÀϹÝÀûÀ¸·Î õ¿¬ Æ®¸®±Û¸®¼¼¶óÀ̵å, À¯¸® Áö¹æ»ê, ¿¡Æ¿ ¿¡½ºÅ׸£, Àç¿¡½ºÅ׸£È­ Æ®¸®±Û¸®¼¼¶óÀ̵å, ÀÎÁöÁú µî ´Ù¾çÇÑ ÇüÅÂÀÇ ¿À¸Þ°¡ 3¸¦ Æ÷ÇÔÇÕ´Ï´Ù.

¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå µ¿Çâ :

¿À¸Þ°¡ 3 °áÇÌÁõÀ» ¾Î°í ÀÖ´Â °³ÀÎÀÇ ¼ö°¡ Å©°Ô Áõ°¡ÇÏ´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â Áß¿äÇÑ ¿ä¼Ò Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ¿À¸Þ°¡ 3 Áö¹æ»êÀº ½ÉÇ÷°ü°èÀÇ °Ç°­À» °³¼±ÇÏ°í ³ú ¼¼Æ÷ °£ÀÇ ÀÇ»ç ¼ÒÅëÀ» °­È­ÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ªÇÒÀ»ÇÕ´Ï´Ù. µû¶ó¼­ ½ÉÀåÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÎÁöÀû °Ç°­¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÁöÇâ Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ¿À¸Þ°¡ 3 Áö¹æ»êÀ» ½Ä´Ü¿¡ µµÀÔÇÏ¿© Ç÷Àü À§ÇèÀ» ÁÙÀÌ°í µ¿¸ÆÀÇ ³»º®À» ºÎµå·´°í ¼Õ»óµÇÁö ¾ÊÀº »óÅ·ΠÀ¯ÁöÇÏ°í Æ®¸®±Û¸®¼¼¸®µå ¼öÄ¡¸¦ ³·Ãß´Â ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ »ý¼± ±â¸§À» ¿ø·á·Î ÇÏ´Â º¸ÃæÁ¦ Áß¿¡´Â ºñºñŸ¹Î,ºñ¹Ì³×¶öÀÇ Ãµ¿¬ Á¦Ç°À¸·Î °£ÁֵǴ °Íµµ ÀÖ¾î, À¯¾Æ³ª ¼ºÀÎ »çÀÌ¿¡¼­ ÀαâÀÇ ¼±ÅÃÁö°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ Á¦Á¶¾÷ü´Â ä½ÄÁÖÀÇÀÚ ¿À¸Þ°¡ 3¿¡ ´ëÇÑ ½Ä»ç ¿ä±¸ »çÇ×À» ÃæÁ·½Ã۱â À§ÇØ Áö¼Ó °¡´ÉÇÑ ½Ä¹° ±â¹Ý º¯ÇüÀ» Á¦°øÇÕ´Ï´Ù. À̴ ä½ÄÁÖÀÇÀÇ »õ·Î¿î µ¿Çâ°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • 2023³â ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå ±Ô¸ð´Â?
  • 2024³â-2032³â ¼¼°è ¿À¸Þ°¡3 º¸ÃæÁ¦ ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • COVID-19°¡ ¼¼°è ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå¿¡ ¹ÌÄ£ ¿µÇâÀº?
  • ¼¼°è ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡,
  • °ø±Þ¿øº° ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå ³»¿ªÀº?
  • Çüź° ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå ³»¿ªÀº?
  • ±â´Éº° ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå ³»¿ªÀº?
  • À¯Åë ä³Îº° ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå ³»¿ªÀº?
  • ÃÖÁ¾ »ç¿ëÀÚº° ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå ³»¿ªÀº?
  • ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¿À¸Þ°¡ 3 º¸ÃæÁ¦ ½ÃÀå¿¡¼­ ÁÖ¿ä ÁøÃâ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä »ê¾÷ µ¿Çâ

Á¦5Àå ¼¼°è ¿À¸Þ°¡3 º¸Ãæ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : °ø±Þ¿øº°

  • »ý¼± ±â¸§
  • Å©¸± ¿ÀÀÏ
  • Á¶·ù ¿ÀÀÏ
  • ±âŸ

Á¦7Àå ½ÃÀå ºÐ¼® : Çüź°

  • Á¤Á¦
  • ĸ½¶
  • ¼ÒÇÁÆ®Á©
  • ±âŸ

Á¦8Àå ½ÃÀå ºÐ¼® : ±â´Éº°

  • ½ÉÇ÷°ü °Ç°­
  • ³ú, ½Å°æ°è, Á¤½Å °Ç°­
  • ¾ÈÁúȯ
  • ´ç´¢º´
  • ±âŸ

Á¦9Àå ½ÃÀå ºÐ¼® : À¯Åëä³Îº°

  • ½ÃÆÇ¾à
  • 󹿾à

Á¦10Àå ½ÃÀå ³»¿ª: ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼ºÀÎ
  • °í·ÉÀÚ ½ÃÀå
  • ÀÓ»êºÎ
  • À¯¾Æ
  • À¯¾Æ

Á¦11Àå ½ÃÀå ºÐ¼®: Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦12Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦13Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦15Àå °¡°Ý ºÐ¼®

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • 1-800-Flowers.com Inc.
    • Aker BioMarine ASA
    • Carlson Labs
    • Green Pasture Products LLC
    • KD Pharma Group
    • Natrol LLC
    • Nordic Naturals Inc.
    • Now Foods
    • NutriGold Inc.
    • OmegaBrite
    • Optimum Nutrition Inc.(Glanbia Performance Nutrition Inc.)
    • Pharma Nord
    • The Bountiful Company
BJH 24.05.07

The global omega 3 supplements market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.06% during 2024-2032.

Omega-3 fatty acids are essential fats found naturally in foods like fish, vegetable oils, nuts, flax seeds, flaxseed oil, and leafy vegetables. They play a pivotal role in the cell membranes of the body for affecting the functions of cell receptors. Their deficiency can lead to dry and irritated skin, inflammation, dry eyes, depression, and arthritis. As a result, there is a rise in the need for over the counter (OTC) omega-3 supplements to help boost the omega-3 levels in the body. These supplements generally contain different forms of omega-3s, including natural triglycerides, free fatty acids, ethyl esters, re-esterified triglycerides, and phospholipids.

Omega 3 Supplements Market Trends:

A significant rise in the number of individuals suffering from omega-3 deficiency represents one of the key factors bolstering the market growth. Moreover, omega-3 fatty acids play an essential role in improving cardiovascular health and enhancing communication between brain cells. Therefore, the increasing prevalence of heart diseases and the growing consumer inclination towards cognitive health are contributing to the market growth. Apart from this, the rising awareness about the benefits of including omega-3 fatty acids in the diet for reducing the risk of blood clots, keeping the lining of the arteries smooth and free from damage, and lowering triglyceride levels is also driving the market. Furthermore, some of these supplements made from fish oil are considered nonvitamin and nonmineral natural products, which makes them a popular choice among children and adults. Besides this, manufacturers are offering sustainably sourced plant-based variants to cater to the dietary requirements of omega-3 among the vegan population. This, along with the emerging trend of veganism, is anticipated to propel market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global omega 3 supplements market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on source, form, functionality, distribution channel, and end user.

Breakup by Source:

Fish Oil

Krill Oil

Algae Oil

Others

Breakup by Form:

Tablets

Capsules

Soft Gels

Others

Breakup by Functionality:

Cardiovascular Health

Brain, Nervous System and Mental Health

Eye Diseases

Diabetes

Others

Breakup by Distribution Channel:

OTC

Prescribed

Breakup by End User:

Adults

Geriatric

Pregnant Women

Children

Infants

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 1-800-Flowers.com Inc., Aker BioMarine ASA, Carlson Labs, Green Pasture Products LLC, KD Pharma Group, Natrol LLC, Nordic Naturals Inc., Now Foods, NutriGold Inc., OmegaBrite, Optimum Nutrition Inc. (Glanbia Performance Nutrition Inc.), Pharma Nord and The Bountiful Company.

Key Questions Answered in This Report

  • 1. What was the size of the global omega 3 supplements market in 2023?
  • 2. What is the expected growth rate of the global omega 3 supplements market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global omega 3 supplements market?
  • 4. What are the key factors driving the global omega 3 supplements market?
  • 5. What is the breakup of the global omega 3 supplements market based on the source?
  • 6. What is the breakup of the global omega 3 supplements market based on the form?
  • 7. What is the breakup of the global omega 3 supplements market based on the functionality?
  • 8. What is the breakup of the global omega 3 supplements market based on the distribution channel?
  • 9. What is the breakup of the global omega 3 supplements market based on the end user?
  • 10. What are the key regions in the global omega 3 supplements market?
  • 11. Who are the key players/companies in the global omega 3 supplements market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Omega 3 Supplements Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Source

  • 6.1 Fish Oil
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Krill Oil
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Algae Oil
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Form

  • 7.1 Tablets
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Capsules
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Soft Gels
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Functionality

  • 8.1 Cardiovascular Health
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Brain, Nervous System and Mental Health
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Eye Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Diabetes
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 OTC
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Prescribed
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Adults
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Geriatric
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pregnant Women
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Children
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Infants
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 1-800-Flowers.com Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Aker BioMarine ASA
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Carlson Labs
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Green Pasture Products LLC
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 KD Pharma Group
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Natrol LLC
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Nordic Naturals Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Now Foods
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 NutriGold Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 OmegaBrite
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Optimum Nutrition Inc. (Glanbia Performance Nutrition Inc.)
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Pharma Nord
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
    • 16.3.13 The Bountiful Company
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦